Dr. Taylor on Ongoing Phase II Trial of Frontline Vemurafenib Combo in Hairy Cell Leukemia
October 25th 2019Justin Taylor, MD, discusses the design of an ongoing phase II clinical trial evaluating the combination of frontline vemurafenib plus obinutuzumab in patients with hairy cell leukemia.
Read More